Company profile

Adagene company profile

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.

Business identity

Contact email
[email protected]
Phone number
+051287773632
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$1K+
Founded
2011-01-01

Headquarters

Headquarters
Fucheng, Shanxi, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
7
Total equity funding
$180M
Last funding
Post Ipo Equity / $25M / 2025-07-01
Last equity funding
Post Ipo Equity / $25M
Investors
12
Lead investors
4
Founders
1
Articles
119
Exited on
2021-02-09

Founders and investors

Founders

Peter (Peizhi) Luo

Lead investors

General AtlanticGP Healthcare CapitalHSGSanofi

Investors

Eight Roads VenturesF-PrimeGeneral AtlanticHSGSanofi

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.